Target Price | $9.49 |
Price | $3.72 |
Potential |
155.09%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Molecular Partners AG - ADR 2026 .
The average Molecular Partners AG - ADR target price is $9.49.
This is
155.09%
register free of charge
$19.21
416.39%
register free of charge
$4.52
21.43%
register free of charge
|
|
A rating was issued by 7 analysts: 5 Analysts recommend Molecular Partners AG - ADR to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Molecular Partners AG - ADR stock has an average upside potential 2026 of
155.09%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 5.64 | 0.57 |
27.97% | 89.98% | |
EBITDA Margin | -1,184.75% | -12,325.03% |
42.04% | 940.30% | |
Net Margin | -1,176.38% | -10,314.39% |
19.00% | 776.79% |
4 Analysts have issued a sales forecast Molecular Partners AG - ADR 2025 . The average Molecular Partners AG - ADR sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Molecular Partners AG - ADR EBITDA forecast 2025. The average Molecular Partners AG - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Molecular Partners AG - ADR 2025 . The average Molecular Partners AG - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.80 | -1.58 |
14.29% | 12.22% | |
P/E | negative | |
EV/Sales | negative |
1 Analysts have issued a Molecular Partners AG - ADR forecast for earnings per share. The average Molecular Partners AG - ADR EPS is
This results in the following potential growth metrics and future valuations:
Molecular Partners AG - ADR...
Analyst | Rating | Action | Date |
---|---|---|---|
TD COWEN |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
Analyst Rating | Date |
---|---|
Locked
TD COWEN:
Locked
➜
Locked
|
Oct 31 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.